MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Phenotypic Spectrum of Movement Disorders in TBC1D24 Gene Variants: A Case Series

    K. Chesky, M. Parnes, M. Hull (Houston, USA)

    Objective: To report the phenotypic spectrum of movement disorders in 5 pediatric patients with TBC1D24 gene variants and provide accompanying video. Background: The TBC1D24 gene…
  • 2025 International Congress

    Effectiveness of Intensive Speech Treatment for Friedreich’s Ataxia

    L. Ramig, H. Hodges, E. Peterson, M. Tran, A. Lowit (Tucson, USA)

    Objective: ​​​​​​1. Test feasibility of providing online intensive speech treatment to people with Friedreich’s Ataxia (FA)2. Compare benefits of two treatment targets (vocal loudness-LSVT LOUD;…
  • 2025 International Congress

    Understanding the Challenges of Treating and Living with Essential Tremor: Results from a Lived-Experience Focus Group

    R. Martuscello, L. Knight, I. Pyle, A. Sanchez Fraga, C. Ferrer, K. Gant, A. Grinspan (Miami, USA)

    Objective: To understand the experience of living with essential tremor (ET), we ran a lived-experience focus group that examined impact of tremor of daily life,…
  • 2025 International Congress

    Clinical and epidemiological characterization of patients with cerebellar ataxia in a reference center in Northeastern Brazil

    V. Chagas, M. Soares, M. Bezerra (Recife, Brazil)

    Objective: To describe the epidemiological and clinical characteristics of patients with cerebellar ataxia in a Movement Disorders outpatient clinic at a public reference center in…
  • 2025 International Congress

    Genetic Ataxias in Argentina

    M. Rossi, M. Merello (Buenos Aires, Argentina)

    Objective: To determine the occurrence and frequency of genetic ataxias in Argentina. Background: Genetic ataxias comprise hundreds of disorders with significant phenotypic, genetic, and epidemiological…
  • 2025 International Congress

    Spinocerebellar Ataxia 15: The first reported case of SCA15 in Asia secondary to ITPR1 gene mutation

    M. Fontanilla, P. Cataniag, M. Orteza, P. Quitasol (Baguio City, Philippines)

    Objective: The objective of this paper is to present the clinical, genetic findings, and inheritance pattern of a family with SCA. Background: Spinocerebellar Ataxia (SCA)…
  • 2025 International Congress

    Co-occurrence of Spinal Muscular Atrophy Type 2 and Huntington’s Disease

    U. Agarwal, S. Fu, Y. Wang, B. Bulica (Detroit, USA)

    Objective: To describe a unique case of co-occurring SMA2 and HD in a patient. Background: Huntington’s Disease (HD) is an autosomal dominant neurodegenerative disorder caused…
  • 2025 International Congress

    Huntington’s Disease: Overview from 20 Years of a Single-Center Experience

    M. Tsalta-Mladenov, M. Levkova, M. Hachmeriyan, L. Angelova (Varna, Bulgaria)

    Objective: This study evaluates patient data from individuals with Huntington’s disease who attended our single tertiary center. Background: Huntington’s disease is an inherited neurodegenerative disorder…
  • 2025 International Congress

    Real-World Clinical and Safety Outcomes from a Prospective, Multicenter Deep Brain Stimulation Registry of Essential Tremor Patients

    G. Deuschl, P. Schuurman, G. Loret, N. Kovacs, M. Barbe, M. Blazquez Estrada, F. Clement, S. Jauma Classen, J. Lee, J. Volkmann, D. Pedrosa, A. Oliviera, S. Paschen, L. Chen, R. Shivacharan, E. Goldberg (Kiel, Germany)

    Objective: Here, we evaluate ongoing registry outcomes derived from patients implanted with directional Deep Brain Stimulation (DBS) systems with Multiple Independent Current Control (MICC) technology…
  • 2025 International Congress

    Beyond “benign”, tremor and epilepsy in FAME3-A New Family Report with Progressive Course and Cognitive Impairment

    D. Campo-Caballero, F. Magrinelli, M. Carazo, M. Maneiro, A. Vinagre-Aragón, E. Mondragón, A. Gabilondo, J. Ruiz-Martínez, L. Blázquez, H. Houlden, P. Iruzubieta (San Sebastian, Spain)

    Objective: To report a family with Familial Cortical Myoclonic Tremor with Epilepsy(FAME) type 3 diagnosed through long-read sequencing and presenting a progressive disease course and…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25111 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley